Laidlaw Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,371
| Closed | -$1.26M | – | 237 |
|
|
2023
Q4 | $1.26M | Sell |
2,371
-15
| -0.6% | -$7.96K | 0.46% | 65 |
|
|
2023
Q3 | $1.21M | Sell |
2,386
-2,612
| -52% | -$1.32M | 0.4% | 76 |
|
|
2023
Q2 | $2.61M | Sell |
4,998
-22
| -0.4% | -$11.5K | 0.51% | 49 |
|
|
2023
Q1 | $2.89M | Sell |
5,020
-116
| -2% | -$66.9K | 0.59% | 43 |
|
|
2022
Q4 | $2.83M | Sell |
5,136
-609
| -11% | -$335K | 0.61% | 42 |
|
|
2022
Q3 | $2.91M | Buy |
5,745
+477
| +9% | +$242K | 0.68% | 35 |
|
|
2022
Q2 | $2.86M | Sell |
5,268
-251
| -5% | -$136K | 0.58% | 41 |
|
|
2022
Q1 | $3.26M | Sell |
5,519
-582
| -10% | -$344K | 0.54% | 45 |
|
|
2021
Q4 | $4.07M | Buy |
6,101
+476
| +8% | +$318K | 0.65% | 34 |
|
|
2021
Q3 | $3.21M | Buy |
+5,625
| New | +$3.21M | 0.82% | 34 |
|
|
2021
Q1 | – | Sell |
-5,088
| Closed | -$2.37M | – | 349 |
|
|
2020
Q4 | $2.37M | Buy |
5,088
+3,049
| +150% | +$1.42M | 0.5% | 55 |
|
|
2020
Q3 | $900K | Buy |
2,039
+76
| +4% | +$33.5K | 0.4% | 74 |
|
|
2020
Q2 | $711K | Buy |
1,963
+60
| +3% | +$21.7K | 0.37% | 77 |
|
|
2020
Q1 | $540K | Buy |
1,903
+328
| +21% | +$93.1K | 0.35% | 84 |
|
|
2019
Q4 | $512K | Buy |
+1,575
| New | +$512K | 0.32% | 92 |
|